Significant Ownership of VIKING GLOBAL INVESTORS LP

Signature - Title
/s/ Scott M. Hendler - Scott M. Hendler on behalf of VIKING GLOBAL INVESTORS LP (1)(2)(3)
Location
Stamford, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by VIKING GLOBAL INVESTORS LP.

Notify me when VIKING GLOBAL INVESTORS LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of VIKING GLOBAL INVESTORS LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CZOOF Cazoo Group Ltd Class A Ordinary Shares, par value $0.20 per share 44% $42,855 2,142,728 VIKING GLOBAL INVESTORS LP 01 Feb 2024
TIC ACUREN CORP Common Stock, par value $0.0001 per share 28% 34,360,000 VIKING GLOBAL INVESTORS LP 31 Mar 2025
INBX Inhibrx Biosciences, Inc. Common Stock, par value $0.0001 per share 10% $106,593,674 1,454,608 VIKING GLOBAL INVESTORS LP 31 Dec 2025
ORIC Oric Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 10% $95,149,860 +$23,507,430 8,729,345 +33% VIKING GLOBAL INVESTORS LP 30 Jun 2025
RLYB Rallybio Corporation Common Stock, par value $0.0001 per share 10% $2,897,379 4,222,969 VIKING GLOBAL INVESTORS LP 31 Dec 2025
BBIO BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share 6.8% $1,040,936,987 -$229,147,279 13,026,367 -18% VIKING GLOBAL INVESTORS LP 12 Feb 2026
SION Sionna Therapeutics, Inc. Common Stock, $0.001 par value per share 6.7% $35,551,158 2,952,754 VIKING GLOBAL INVESTORS LP 10 Feb 2025
FTV Fortive Corp Common Stock, par value $0.01 per share 6.4% $1,003,495,483 +$168,256,253 20,483,680 +20% VIKING GLOBAL INVESTORS LP 30 Sep 2025
Veradermics, Inc Common Stock, par value $0.00001 per share 5.8% 2,151,493 VIKING GLOBAL INVESTORS LP 05 Feb 2026
CHWY Chewy, Inc. Class A Common Stock, par value $0.01 per share 5.7% $463,223,992 13,536,645 VIKING GLOBAL INVESTORS LP 18 Dec 2025
ORKA Oruka Therapeutics, Inc. Common Stock, $0.001 par value per share 5.5% $38,693,672 2,666,690 VIKING GLOBAL INVESTORS LP 17 Sep 2025
PEPG PepGen Inc. Common Stock, par value $0.0001 per share 5.1% $4,178,921 3,482,434 VIKING GLOBAL INVESTORS LP 26 Sep 2025
RRX REGAL REXNORD CORP Common Stock, $0.01 par value per share 5% $463,272,794 +$25,016,671 3,301,545 +5.7% VIKING GLOBAL INVESTORS LP 06 Jan 2026
BMRN BIOMARIN PHARMACEUTICAL INC Common Stock, par value $0.001 per share 4.3% $450,729,215 -$214,821,957 8,322,179 -32% VIKING GLOBAL INVESTORS LP 30 Sep 2025
TRVI Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share 4.2% $46,929,206 -$21,747,894 5,128,875 -32% VIKING GLOBAL INVESTORS LP 30 Sep 2025
SAIA SAIA INC Common Stock, par value $0.001 per share 4.1% $384,280,332 -$87,819,710 1,088,582 -19% VIKING GLOBAL INVESTORS LP 31 Dec 2025
NAMS NewAmsterdam Pharma Co N.V. Ordinary Shares, nominal value EUR0.12 per share 3.7% $144,476,598 -$95,375,616 4,203,567 -40% VIKING GLOBAL INVESTORS LP 31 Dec 2025
ROIV Roivant Sciences Ltd. Common Shares, $0.0000000341740141 par value per share 3.4% $356,989,793 -$161,027,803 23,594,831 -31% VIKING GLOBAL INVESTORS LP 30 Sep 2025
APG APi Group Corp Common Stock, $0.0001 par value per share 2.8% $397,005,994 -$344,100,000 11,537,518 -46% VIKING GLOBAL INVESTORS LP 30 Jun 2025
PRMB Primo Brands Corp Class A Common Stock, $0.01 par value per share 0% $0 -$355,582,384 0 -100% VIKING GLOBAL INVESTORS LP 31 Dec 2025
LBPH Longboard Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 0% $0 0 VIKING GLOBAL INVESTORS LP 31 Dec 2024

Schedules 13D/G Reported by VIKING GLOBAL INVESTORS LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.